Back

Derivation and validation of a multicenter model to identify candidates for advanced HF therapies with high potential to achieve post-LVAD reverse cardiac remodeling

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Heart transplantation, LVADs and inotropic support in heart failure: challenges and expectations Ventricular Assist Devices ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Stavros Drakos

University of Utah, Salt Lake City (United States of America)

7 More presentations in this session

Presentation thumbnail
Long-term outcomes of heart re-transplantation from HCV-viremic donors based on UNOS registry
Doctor M. Mazur (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Extending the window in clinical decision making: the role for Impella 5.5 in cardiogenic shock
Associate Professor R. Goswami (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Home alone on milrinone: a novel way to deliver home inotropes as a bridge to heart transplantation
Ms K. Easton (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
CMR predictors of acute right heart failure after LVAD implantation
Doctor F. Coraducci (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Associated factors and percentage of cardiac recovery among patients using LVAD: a meta-analysis of 31 studies
Doctor E. Hasabo (Galway, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart transplantation, LVADs and inotropic support in heart failure: challenges and expectations

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting
thumbnail
Congress Presentation
Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin
thumbnail
Congress Presentation
Reverse cardiac remodelling Looking beyond the LVAD. Mitral valve replacement and LVAD explant in a Titin Dilated Cardiomyopathy (TTN-DCM) patient after myocardial recovery.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources